Skip to main content
Log in

Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson’s Disease

  • Report
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disorder and has an elusive etiology. It is likely multifactorial, and genetic defects contribute to its pathogenesis. At least 25 genetic loci and 20 monogenic genes have been identified in monogenic PD. Recessive F-box protein 7 gene (FBXO7) mutations reportedly cause hereditary parkinsonism. To explore the roles of four paralogs (FBXO2, FBXO6, FBXO12, and FBXO41) in PD development, their variants (rs9614, rs28924120, rs6442117, and rs61733550, respectively) were analyzed in 502 Han Chinese patients with PD and 556 age, gender, and ethnicity-matched normal participants in mainland China. Statistically significant differences in genotypic and allelic frequencies were detected only in the FBXO2 variant rs9614 (P = 0.001 and 0.023, respectively; odds ratio 0.819, 95% confidence interval 0.690–0.973) between patients and controls. These results suggest that the FBXO2 variant rs9614 C allele may decrease the PD risk in mainland Han Chinese and may be a biomarker for PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Farlow JL, Robak LA, Hetrick K, Bowling K, Boerwinkle E, Coban-Akdemir ZH, et al. Whole-exome sequencing in familial Parkinson disease. JAMA Neurol 2016, 73: 68–75.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JA. Advances in understanding genomic markers and pharmacogenetics of Parkinson’s disease. Expert Opin Drug Metab Toxicol 2016, 12: 433–448.

    Article  CAS  PubMed  Google Scholar 

  3. Cai Z, Zeng W, Tao K, E Z, Wang B, Yang Q. Chaperone-mediated autophagy: roles in neuroprotection. Neurosci Bull 2015, 31: 452–458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol 2006, 5: 525–535.

    Article  PubMed  Google Scholar 

  5. Kalinderi K, Bostantjopoulou S, Fidani L. The genetic background of Parkinson’s disease: current progress and future prospects. Acta Neurol Scand 2016, 134: 314–326.

    Article  CAS  PubMed  Google Scholar 

  6. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 2015, 30: 1591–1601.

    Article  PubMed  Google Scholar 

  7. Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, et al. Identification of TMEM230 mutations in familial Parkinson’s disease. Nat Genet 2016, 48: 733–739.

    Article  CAS  PubMed  Google Scholar 

  8. Martins-Branco D, Esteves AR, Santos D, Arduino DM, Swerdlow RH, Oliveira CR, et al. Ubiquitin proteasome system in Parkinson’s disease: a keeper or a witness? Exp Neurol 2012, 238: 89–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lin CH, Chen ML, Lai TT, Tai CH, Wu RM. Mutational analysis of FBXO7 gene in Parkinson’s disease in a Taiwanese population. Neurobiol Aging 2013, 34: 1713.e1–1713.e4.

  10. Salat D, Noyce AJ, Schrag A, Tolosa E. Challenges of modifying disease progression in prediagnostic Parkinson’s disease. Lancet Neurol 2016, 15: 637–648.

    Article  PubMed  Google Scholar 

  11. Lu S, Zhou J. Finding the ‘guilty’ gene variant of sporadic Parkinson’s disease via CRISPR/Cas9. Neurosci Bull 2017, 33: 115–117.

    Article  PubMed  Google Scholar 

  12. Yuan L, Song Z, Deng X, Zheng W, Guo Y, Yang Z, et al. Systematic analysis of genetic variants in Han Chinese patients with sporadic Parkinson’s disease. Sci Rep 2016, 6: 33850.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hernandez DG, Reed X, Singleton AB. Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem 2016, 139 Suppl 1: 59–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sudhaman S, Muthane UB, Behari M, Govindappa ST, Juyal RC, Thelma BK. Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson’s disease with non-motor phenotypes. J Med Genet 2016, 53: 559–566.

    Article  PubMed  Google Scholar 

  15. Toft M, Mata IF, Kachergus JM, Ross OA, Farrer MJ. LRRK2 mutations and Parkinsonism. Lancet 2005, 365: 1229–1230.

    Article  PubMed  Google Scholar 

  16. Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 2010, 31: 561–568.

    CAS  PubMed  Google Scholar 

  17. Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson’s disease: a case-control study. Lancet Neurol 2011, 10: 898–908.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Noyce AJ, Lees AJ, Schrag AE. The prediagnostic phase of Parkinson’s disease. J Neurol Neurosurg Psychiatry 2016, 87: 871–878.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Soto-Ortolaza AI, Ross OA. Genetic susceptibility variants in parkinsonism. Parkinsonism Relat Disord 2016, 22 Suppl 1: S7–S11.

    Article  PubMed  Google Scholar 

  20. Yuan L, Song Z, Deng X, Xiong W, Yang Z, Deng H. Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson’s disease patients. Neurosci Lett 2016, 616: 26–31.

    Article  CAS  PubMed  Google Scholar 

  21. Tan T, Song Z, Yuan L, Xiong W, Deng X, Ni B, et al. Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson’s disease. Neurosci Lett 2016, 612: 189–192.

    Article  CAS  PubMed  Google Scholar 

  22. Shojaee S, Sina F, Banihosseini SS, Kazemi MH, Kalhor R, Shahidi GA, et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am J Hum Genet 2008, 82: 1375–1384.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Di Fonzo A, Dekker MC, Montagna P, Baruzzi A, Yonova EH, Correia Guedes L, et al. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 2009, 72: 240–245.

    Article  PubMed  Google Scholar 

  24. Lohmann E, Coquel AS, Honore A, Gurvit H, Hanagasi H, Emre M, et al. A new F-box protein 7 gene mutation causing typical Parkinson’s disease. Mov Disord 2015, 30: 1130–1133.

    Article  CAS  PubMed  Google Scholar 

  25. Conedera S, Apaydin H, Li Y, Yoshino H, Ikeda A, Matsushima T, et al. FBXO7 mutations in Parkinson’s disease and multiple system atrophy. Neurobiol Aging 2016, 40: 192.e1–192.e5.

  26. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008, 79: 368–376.

    Article  CAS  PubMed  Google Scholar 

  27. Yuan L, Deng X, Song Z, Yang Z, Ni B, Chen Y, et al. Genetic analysis of the RAB39B gene in Chinese Han patients with Parkinson’s disease. Neurobiol Aging 2015, 36: 2907.e11–2907.e12.

  28. Guo Y, Tan T, Deng X, Song Z, Yang Z, Yang Y, et al. TCEANC2 rs10788972 and rs12046178 variants in the PARK10 region in Chinese Han patients with sporadic Parkinson’s disease. Neurobiol Aging 2015, 36: 3335.e1–3335.e2.

  29. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 2001, 98: 581–584.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Xiu X, Song Z, Gao K, Deng X, Qi Y, Zhu A, et al. Genetic analysis of the FBXO48 gene in Chinese Han patients with Parkinson disease. Neurosci Lett 2013, 541: 224–226.

    Article  CAS  PubMed  Google Scholar 

  31. Johansen P, Andersen JD, Borsting C, Morling N. Evaluation of the iPLEX® Sample ID Plus Panel designed for the Sequenom MassARRAY® system. A SNP typing assay developed for human identification and sample tracking based on the SNPforID panel. Forensic Sci Int Genet 2013, 7: 482–487.

  32. Ilyin GP, Serandour AL, Pigeon C, Rialland M, Glaise D, Guguen-Guillouzo C. A new subfamily of structurally related human F-box proteins. Gene 2002, 296: 11–20.

    Article  CAS  PubMed  Google Scholar 

  33. Deng H, Liang H, Jankovic J. F-box only protein 7 gene in parkinsonian-pyramidal disease. JAMA Neurol 2013, 70: 20–24.

    Article  PubMed  Google Scholar 

  34. Kang J, Chung KC. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE). Cell Mol Life Sci 2015, 72: 181–195.

    Article  CAS  PubMed  Google Scholar 

  35. Burchell VS, Nelson DE, Sanchez-Martinez A, Delgado-Camprubi M, Ivatt RM, Pogson JH, et al. The Parkinson’s disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat Neurosci 2013, 16: 1257–1265.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the participants and investigators involved in this study. This work was supported by the National Key Research and Development Program of China (2016YFC1306604), the National Basic Research Development Program of China (2014CB542400), the National Natural Science Foundation of China (81271921 and 81670216), the Natural Science Foundation of Hunan Province, China (2015JJ4088 and 2016JJ2166), the Construction Fund for Key Subjects of the Third Xiangya Hospital of Central South University (Clinical Laboratory Diagnostics), the New Xiangya Talent Project of the Third Xiangya Hospital of Central South University (20150301), Mittal Students’ Innovative Project of Central South University (15MX50 and 15MX53), and the National-level College Students’ Innovative Training Plan Program of China (201610533288, 201610533290 and 201610533292).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hongwei Lu or Hao Deng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, L., Song, Z., Deng, X. et al. Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson’s Disease. Neurosci. Bull. 33, 510–514 (2017). https://doi.org/10.1007/s12264-017-0122-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-017-0122-5

Keywords

Navigation